Lindsay Reynolds to Cardiovascular Diseases
This is a "connection" page, showing publications Lindsay Reynolds has written about Cardiovascular Diseases.
Connection Strength
0.687
-
Reynolds LM, Zamora C, Lee UJ, Stokes AC, Benjamin EJ, Bhatnagar A, Payne TJ, Rodriguez CJ. Tobacco Use Prevalence and Transitions From 2013 to 2018 Among Adults With a History of Cardiovascular Disease. J Am Heart Assoc. 2021 Jun 15; 10(12):e021118.
Score: 0.435
-
Conklin DJ, Schick S, Blaha MJ, Carll A, DeFilippis A, Ganz P, Hall ME, Hamburg N, O'Toole T, Reynolds L, Srivastava S, Bhatnagar A. Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation. Am J Physiol Heart Circ Physiol. 2019 04 01; 316(4):H801-H827.
Score: 0.092
-
Stokes A, Collins JM, Berry KM, Reynolds LM, Fetterman JL, Rodriguez CJ, Siegel MB, Benjamin EJ. Electronic Cigarette Prevalence and Patterns of Use in Adults with a History of Cardiovascular Disease in the United States. J Am Heart Assoc. 2018 04 26; 7(9).
Score: 0.088
-
Ding J, Reynolds LM, Zeller T, Müller C, Lohman K, Nicklas BJ, Kritchevsky SB, Huang Z, de la Fuente A, Soranzo N, Settlage RE, Chuang CC, Howard T, Xu N, Goodarzi MO, Chen YD, Rotter JI, Siscovick DS, Parks JS, Murphy S, Jacobs DR, Post W, Tracy RP, Wild PS, Blankenberg S, Hoeschele I, Herrington D, McCall CE, Liu Y. Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease. Diabetes. 2015 Oct; 64(10):3464-74.
Score: 0.072